|
|
News Breaks | | | | October 30, 2012 | | 07:04 EDT |  | SIAL | Sigma-Aldrich enters into agreement with CrystalGenomics
Sigma-Aldrich announced that its custom manufacturing and services business unit, SAFC, has signed an agreement with Seoul, South Korea-based CrystalGenomics to support the development of active pharmaceutical ingredients for next-generation non-steroidal anti-inflammatory drugs. CrystalGenomics is developing three clinical stage candidates. The lead program is a next-generation NSAID for osteoarthritis and is in phase 3 development. In addition to next-generation NSAID, the company is developing multiple novel candidates in various stages of development for various therapeutic areas with focus on inflammation, oncology, CNS and infection. | |
|
News For SIAL From The Last 14 Days Check below for free stories on SIAL the last two weeks. |
|
|
| June 14, 2013 | | 09:56 EDT |  | SIAL | Sigma-Aldrich has a conference call hosted by JPMorgan
JPMorgan Analysts Peterson, Lodes and Donthamsetty will host a conference call with CEO Rakesh Sachdev on June 21 at 11 am. | | | June 11, 2013 | | 07:31 EDT | | SIAL | Goldman to host a conference
 Subscribe for More Information | |
|
|
|
|
|
|
